Paul Brinkman

Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study

Fulfilling the Promise of Breathomics: Considerations for the Discovery and Validation of Exhaled Volatile Biomarkers

Discovery and Validation of a Volatile Signature of Eosinophilic Airway Inflammation in Asthma

Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study

Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics

Association of blood inflammatory phenotypes and asthma burden in children with moderate-to-severe asthma

Oropharyngeal Microbiota Clusters in Children with Asthma or Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways, and Exacerbation Risk

Exhaled metabolite profiling for asthma control classification in children: results from the SysPharmPediA study

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

Multi‐ancestry genome‐wide association study of asthma exacerbations

Analysis of Metabolites in Exhaled Breath for the Phenotyping of Eosinophilic Asthma in Children

Association of DNA methylation with fractional exhaled nitric oxide levels in pediatric asthma

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes

A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric Asthma

Expert meeting report: towards a joint European roadmap to address the unmet needs and priorities of paediatric asthma patients on biologic therapy

Advances in Artificial Olfaction Systems: Obviously Artificial, Somewhat Olfactive

Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months

eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy

The burden of severe asthma in children and youths in Europe

IL-17–high asthma with features of a psoriasis immunophenotype

Stratification of asthma phenotypes by airway proteomic signatures

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma

Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project

A European Respiratory Society technical standard: exhaled biomarkers in lung disease

Pathway discovery using transcriptomic profiles in adult-onset severe asthma

Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study

Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma

U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics